Loading…

Clinicopathological features of appendiceal goblet cell adenocarcinoma in Japan: a multicenter retrospective study

Purpose In the 5th edition of the World Health Organization classification, appendiceal goblet cell adenocarcinoma (GCA) is categorized separately from neuroendocrine tumors and other appendiceal adenocarcinomas. We clarified the clinicopathological characteristics of Japanese appendiceal GCA. Metho...

Full description

Saved in:
Bibliographic Details
Published in:Surgery today (Tokyo, Japan) Japan), 2023-02, Vol.53 (2), p.174-181
Main Authors: Shiota, Tetsuya, Murata, Kohei, Kishimoto, Mitsuo, Yao, Takashi, Noura, Shingo, Morita, Shunji, Akiyoshi, Takashi, Okamura, Shu, Imasato, Mitsunobu, Furuhata, Tomohisa, Suto, Takeshi, Takemasa, Ichiro, Shingai, Tatsushi, Ueda, Masami, Mizuno, Hitoshi, Hisamatsu, Yuichi, Takeda, Takashi, Fujii, Makoto, Kagawa, Yoshinori, Sugihara, Kenichi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose In the 5th edition of the World Health Organization classification, appendiceal goblet cell adenocarcinoma (GCA) is categorized separately from neuroendocrine tumors and other appendiceal adenocarcinomas. We clarified the clinicopathological characteristics of Japanese appendiceal GCA. Methods We designed a retrospective multicenter cohort study and retrieved the data of patients with appendiceal neoplasms and histologically diagnosed appendiceal goblet cell carcinoid (GCC) treated from January 2000 to December 2017 in Japan. The available GCC slides were reviewed and diagnosed with a new grading system of GCA. Results A total of 922 patients from 43 institutions were enrolled; of these, 32 cases were patients with GCC (3.5%), and 20 cases were ultimately analyzed. The 5-year survival rate was 61.4% (95% confidence interval: 27.4–83.2), and the median survival time was 93.1 months. For peritoneal metastasis, regional lymph node metastasis was a significant factor ( p  = 0.04), and Grade 3 was a potential factor ( p  = 0.07). No peritoneal metastasis was observed in either T1/2 patients ( n  = 2) or Grade 1 patients ( n  = 4). We were unable to detect any significant factors associated with regional lymph node metastasis. Conclusion For peritoneal metastasis, regional lymph node metastasis was a significant factor, and Grade 3 was a potential factor.
ISSN:0941-1291
1436-2813
DOI:10.1007/s00595-022-02562-z